Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis

NCT02150343 is registered in ClinicalTrials.gov with Circassia Limited as lead sponsor.

NCT NCT02150343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02150343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomised, Placebo-Controlled, Multi-Centre Field Study to Assess the Efficacy and Safety of HDM-SPIRE in Subjects With a History of House Dust Mite-Induced Rhinoconjunctivitis
Lead sponsor
Circassia Limited
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2014
Completion date
April 13, 2017
Enrollment
715 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

rhinoconjunctivitis